Image of Leonid Lecca

Leonid Lecca, M.D.

617-432-1707

Dr. Lecca is an international expert on global health. He earned his MD from Cayetano Heredia Peruvian University, where also holds his MSc in Epidemiology and Health Management. Last year, he participated in the Global Health Intensive Program at Harvard T.H. Chan School of Public Health.

Dr. Lecca is also the Executive Director at Partners In Health in Peru, and serve as the principal investigator for numerous NIH and Grand Challenges of Canada grants among others, oversees a staff of 250, manages relationships with government, and facilitates the participation of students and research affiliates on various projects at the PIH site and throughout Peru. In the past, Dr. Lecca worked as a technical advisor in infectious disease projects at U.S. Agency for International Development, and was the Human Research Protection Administrator at the Peruvian National Institute of Health. 

Leonid Lecca, MD, MSc is a Lecture in the Department of Global Health and Social Medicine at Harvard Medical School. His research focuses on the epidemiology of tuberculosis, multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, HIV/AIDS, maternal-health, mental health, chronic diseases and community-based approaches to dealing with public health problems, social responsibility, and public health approaches in global health. Current projects include:

  • The discovery and development of innovative TB Diagnostics.
  • Finding and treating unsuspected and resistant TB to reduce hospital transmission.
  • Identification of metabolic factors that control the spectrum of human tuberculosis.
  • Clinical trials for TB, MDR-TB and XDR-TB.
  • Study of community-based family coaching interventions to improve neurodevelopment in at-risk children.
  • An innovative interdisciplinary approaches to sustainable airborne infection control.
  • Clinical and programmatic outcomes of a community-based antiretroviral therapy program for HIV positive patients.
Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
Authors: Authors: Byrne AL, Marais BJ, Mitnick CD, Garden FL, Lecca L, Contreras C, Yauri Y, Garcia F, Marks GB.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
Authors: Authors: Shu E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, Galea JT, Lecca L, Sanchez J, Lama JR.
Int J Tuberc Lung Dis
View full abstract on Pubmed
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
Authors: Authors: Bouton TC, Phillips PPJ, Mitnick CD, Peloquin CA, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Horsburgh CR.
Trials
View full abstract on Pubmed
Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
Authors: Authors: Nathavitharana RR, Shi CX, Chindelevitch L, Calderon R, Zhang Z, Galea JT, Contreras C, Yataco R, Lecca L, Becerra MC, Murray MB, Cohen T.
Emerg Infect Dis
View full abstract on Pubmed
Development and Validation of a Food Frequency Questionnaire to Estimate Intake among Children and Adolescents in Urban Peru.
Authors: Authors: Rodriguez CA, Smith ER, Villamor E, Zavaleta N, Respicio-Torres G, Contreras C, Perea S, Jimenez J, Tintaya K, Lecca L, Murray MB, Franke MF.
Nutrients
View full abstract on Pubmed
Mental disorders and drug/alcohol use in patients commencing extensively drug-resistant tuberculosis treatment.
Authors: Authors: Scuffell J, Boccia D, Garcia Velarde F, Leon SR, Raviola G, Lecca L, Galea JT.
Public Health Action
View full abstract on Pubmed
Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.
Authors: Authors: Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB.
Clin Infect Dis
View full abstract on Pubmed
Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
Authors: Authors: Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito ES, Vasquez DV, Mitnick CD, Davies G.
Antimicrob Agents Chemother
View full abstract on Pubmed
Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
Authors: Authors: Calderón RI, Velásquez GE, Becerra MC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Kritski AL, Murray MB, Mitnick CD.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
Authors: Authors: Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G.
Antimicrob Agents Chemother
View full abstract on Pubmed